Paul Edwards5 said:Has anyone here dealt with anything remotely similar to this?🤷
A mesenchymal tumor is essentially a sarcoma. Unfortunately, we’re dealing with a rare breed here, and they tend to be incredibly aggressive. There are dozens of different types out there, all varying wildly in malignancy depending on where they take root and what stage they've reached. Generally speaking, when you're facing a sarcoma, the reality is pretty blunt: finding an effective chemotherapy is often a massive uphill battle, which means surgical removal remains the gold standard and our best shot at getting ahead of it.
When it comes to Dr. Herceg, he’s easily one of the top experts out there for rare tumors—specifically sarcomas—alongside Dr. Šantek. If you're looking for someone who actually knows their stuff regarding those specific cases in the US, they're the ones. Look, the guy isn't bad; he just carries himself with this certain level of defensiveness and a hint of arrogance that can be off-putting. But don't let that throw you. At the end of the day, he's someone you can actually sit down and have an honest, open conversation with.
Nolvadex did exactly what it was designed to do—it slowed down that tumor growth. It did its job. But unfortunately, when a relapse happens, you're facing the reality of the situation.
Here’s my take on this.
You absolutely have to seek out a second opinion abroad at one of those specialized centers of excellence dedicated to sarcomas. Don't just settle for whatever is right in front of you; go where the real experts are. America is far too small to offer any real opportunities for clinical trials regarding these kinds of rare tumors. Because the patient pool is so tiny, the specialized knowledge and research just aren't there. It’s a harsh reality: whatever advanced treatment you might need next, there is a massive chance it won't be covered by Medicare. You'll likely be left footing the bill yourself for incredibly expensive drugs, and even if you have the money, fighting through the red tape to get them approved can be an absolute nightmare. Honestly, my advice? Get out of the country however you can. If I were in your shoes, I’d look into Dr. Paolo Casali at the National Cancer Institute in Milan. Do some digging online—their website and contact info should be easy enough to find.